Advertisement
Screener

SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) Form 20-F: Annual report of foreign private issuer

SCINAI IMMUNOTHERAPEUTICS LTD. Form 20-F: Annual report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-04-01: Form 20-F; Period of report 2025-12-31; Description ANNUAL REPORT; Document ea0283609-20f_scinai.htm.
  • 2025-05-07: Form 20-F; Period of report 2024-12-31; Description ANNUAL REPORT; Document ea0239669-20f_scinai.htm.
  • 2024-05-15: Form 20-F; Period of report 2023-12-31; Description ANNUAL REPORT; Document ea0205908-20f_scinai.htm.
  • 2022-03-28: Form 20-F; Period of report 2021-12-31; Description ANNUAL REPORT; Document f20f2021_biondvax.htm.
FiledFormPeriod of reportDescriptionDocument
2026-04-0120-F2025-12-31ANNUAL REPORTea0283609-20f_scinai.htm
2025-05-0720-F2024-12-31ANNUAL REPORTea0239669-20f_scinai.htm
2024-05-1520-F2023-12-31ANNUAL REPORTea0205908-20f_scinai.htm
2022-03-2820-F2021-12-31ANNUAL REPORTf20f2021_biondvax.htm
2021-05-1320-F2020-12-31ANNUAL REPORTf20f2020_biondvax.htm
2020-06-1220-F2019-12-31ANNUAL REPORTf20f2019_biondvaxpharma.htm
2019-04-3020-F2018-12-31ANNUAL REPORTf20f2018_biondvaxpharma.htm
2018-04-3020-F2017-12-31ANNUAL REPORTf20f2017_biondvaxpharma.htm
2017-04-2820-F2016-12-31ANNUAL REPORTf20f2016_biondvaxpharma.htm
2016-04-2720-F2015-12-31ANNUAL AND TRANSITION REPORT OF FOREIGN PRIVATE ISSUERSf20f2015_biondvaxpharma.htm